Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions
Pan, E.Y.; Sobieraj, D.M.
Connecticut Medicine 80(2): 105-111
2016
ISSN/ISBN: 0010-6178 PMID: 27024982 Document Number: 689385
Document emailed within 1 workday
Related Documents
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168O'Reilly, R.A. 1974: Drug interactions involving oral anticoagulants Cardiovascular Clinics 6(2): 23-41
Sawicka-Powierza, J.; Rogowska-Szadkowska, D.; Ołtarzewska, A.M.łg.; Chlabicz, S.ła. 2008: Factors influencing activity of oral anticoagulants. Interactions with drugs and food Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(143): 458-462
Apostoae, F.; Tarţău, L.; Cimpoeşu, D.; Lupuşoru, C.ăt.ăl.E. 2011: Pharmacoepidemiologic investigations about the interactions between oral anticoagulants and other drugs in patients with hemostasis disorders Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(4): 1155-1161
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Simborg, D.W. 1976: Medication prescribing on a university medical service-the incidence of drug combinations with potential adverse interactions Johns Hopkins Medical Journal 139(1): 23-26
Loriot, M.-A.; Beaune, P. 2007: Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety La Revue du Praticien 57(12): 1281-1286
Borcherding, S.M.; Stevens, R.; Nicholas, R.A.; Corley, C.R.; Self, T. 1996: Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions Journal of Family Practice 42(1): 69-78
Perry, S.H.; Swamy, P.; Preidis, G.A.; Mwanyumba, A.; Motsa, N.; Sarero, H.N. 2014: Implementing the Jadelle implant for women living with HIV in a resource-limited setting: concerns for drug interactions leading to unintended pregnancies Aids 28(5): 791-793
Perry, S.H.; Swamy, P.; Preidis, G.A.; Mwanyumba, A.; Motsa, N.; Sarero, H.N. 2014: Implementing the Jadelle implant for women living with HIV in a resource-limited setting: concerns for drug interactions leading to unintended pregnancies Aids 28(5): 791-793
Garvey, R. 2006: Target specific seminars in drug discovery--IBC conference. 24-26 April 2006, Berlin, Germany IDrugs: the investigational drugs journal 9(7): 474-475
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Lavarenne, J.; Paire, M. 1990: Interactions de la contraception orale. III, contraception orale et médicaments divers - Drug interactions with oral contraceptives la Lettre du Pharmacologue (Boulogne) 4(5): 138-140
Halal, C.L. 1991: Drug dependency in the renal care setting: Part i Nephrology News and Issues 5(1): 24-25; 28, 47
Staiger, C. 1982: Oral contraceptives. Clinical pharmacology, pharmacokinetics and drug interactions Münchener Medizinische Wochenschrift 124(20): 495-498
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Barkin, R.L.; Barkin, D. 2001: Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection Southern Medical Journal 94(8): 756-770